In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world’s largest pharmaceutical company announced large research and development cuts were on…
It seems that months of merger talks between French pharma Sanofi-Aventis and U.S. biotech Genzyme have entered the home stretch. This week, Sanofi is expected to offer $74 a share for Genzyme, with an option included potential…
Pfizer reported fourth-quarter earnings on Tuesday that nearly quadrupled from a year ago as revenue rose 6%. But it also lowered its sales guidance for 2012, due to some of its bestselling drugs going off patent. What’s ahead …
Social-networking giant Facebook made a bit of progress in its five-year effort to trademark the world “face,” at least when used in things like online chat rooms and social-networking efforts. The company received what’s calle…
In the latest round of a fight between two technology giants, Motorola punched back at Microsoft Wednesday with a patent infringement lawsuit. Its subsidiary, Motorola Mobility, filed 16 infringement claims against the software…